CarbAcineto NP test for rapid detection of carbapenemase-producers in Acinetobacter spp.
- Dortet, Laurent INSERM U914 “Emerging Resistance to Antibiotics”, Faculté de Médecine Paris Sud, K. -Bicêtre, France
- Poirel, Laurent INSERM U914 “Emerging Resistance to Antibiotics”, Faculté de Médecine Paris Sud, K. -Bicêtre, France - Medical and Molecular Microbiology, Department of Medecine, Faculty of Science, University of Fribourg, Switzerland
- Errera, Caroline INSERM U914 “Emerging Resistance to Antibiotics”, Faculté de Médecine Paris Sud, K. -Bicêtre, France
- Nordmann, Patrice INSERM U914 “Emerging Resistance to Antibiotics”, Faculté de Médecine Paris Sud, K. -Bicêtre, France - Medical and Molecular Microbiology, Department of Medecine, Faculty of Science, University of Fribourg, Switzerland
-
23.04.2014
Published in:
- Journal of Clinical Microbiology. - 2014, p. JCM.00594–14
English
Multidrug-resistant Acinetobacter baumannii isolates, and particularly carbapenemase-producing isolates, are increasingly reported worldwide. The biochemically-based Carba NP test, extensively validated for detection of carbapenemase producers among Enterobacteriaceae and Pseudomonas spp., has been modified for the detection of carbapenemase production in Acinetobacter spp. A collection of 151 carbapenemase-producing and 69 non-carbapenemase producing Acinetobacter spp. using the Carba NP test and a modified Carba NP protocol (CarbAcineto NP test) set up in this study. The CarbAcineto NP test requires modified lysis conditions and an increased bacterial inoculum as compared to the original Carba NP test. The Carba NP test detects metallo-β-lactamase producers but failed to detect production of other carbapenemase types among Acinetobacter spp. By contrast, the newly-designed CarbAcineto NP test, which is rapid and reproducible, detects all types of carbapenemases, with a sensitivity of 94.7% and a specificity of 100%. This cost-effective technique offers a reliable and affordable technique for identification of carbapenemase production in Acinetobacter spp., which is a marker of multidrug resistance in those species. Its use will facilitate their recognition and prevent their spread.
- Faculty
- Faculté des sciences et de médecine
- Department
- Médecine 3ème année
- Language
-
- English
- Classification
- Pathology, clinical medicine
- License
- License undefined
- Identifiers
-
- RERO DOC 210115
- DOI 10.1128/JCM.00594-14
- Persistent URL
- https://folia.unifr.ch/unifr/documents/303726
Statistics
Document views: 51
File downloads:
- nor_cnt.pdf: 100